There will be limited parking available at the Binyanei HaUmah (30 NIS for the day). In the case that there is no parking left at the Summit venue, there will be reserved spots available for Summit attendees in the Cinema City underground parking (a 5-minute walk from the venue). In order to gain access to Cinema City parking, please present the email you received about parking on February 13th, as a Summit attendee. If you will be driving please refer to this map for details.
We are excited to collaborate with Fanzone, a transportation platform for event attendees. The event’s official transportation platform, powered by Fanzone, offers attendees the option to share a ride with other attendees, share a taxi, and navigate to the nearest parking. Get started.
We’re pleased to announce a brand new add-on for the 2017 OurCrowd Global Investor Summit: Experience the event with the OurCrowd App!
With the OurCrowd App:
- Participate in hands-on startup growth on OurNetwork
- Receive push notifications with Summit announcements
- Follow the Summit feed for extra content
- Stay on top of your schedule with full agenda view
- Relive the Summit with photos, video and more after the event
Test your ‘Rolodex’ on OurNetwork in the OurCrowd App and play the role of business development partner by matching startups with strategic connections.
Throughout the Summit halls, engage with sector-themed LED screens displaying startups’ strategic requests and fulfill them on the app.
After decades of being at the forefront of life sciences, specifically in medical technology innovation, Israel is now leading the way in another area of health care and advancement: brain science.
Already well known for research and developments in the areas of robotics, optics, immunology, pharma, early disease detection, and surgery, Israeli start-ups are now making significant strides in neurology. 2015, in fact, saw the launch of Israel’s first braintech accelerator, Brainnovations, operating out of Tel Aviv.
Disruptions in the detection and treatment of brain-related disease and functionality are sorely needed, and companies around the world are emerging with solutions related to Alzheimer’s, Stem Cell Therapy, central nervous system diseases, psychiatric disorders and more. We’re excited about what we’re seeing in Israeli brain innovation, in particular. Here are a few companies developing solutions that address significant neurological issues:
- ElMindA was founded in 2006 with the vision of revolutionizing the management of brain disorders and injuries. They’ve developed the world’s first FDA-cleared neuronal functional assessment tool. EIMindA’s solution uniquely measures how different parts of the brain communicate by uploading measured neural activity into the cloud. Proprietary algorithms then map out neural association. This approach captures objective, physical evidence that may elude physicians, offering insight to or explanation of a patient’s symptoms, behaviors, and brain functions.
- Surgical Theater is a company that has developed software combining the science of flight simulation with advanced CT/MRI imaging technology. Using Surgical Theater, surgeons may perform a 3D “flight simulation” of surgery before an actual operation. The company’s Surgery Rehearsal Platform (SRP) is the only commercial, patented, and FDA-cleared platform for cerebral and spine pre-surgery rehearsal on the market. Research indicates that surgeons who use virtual reality and simulators operate with decreased risk and ultimately see better outcomes.
- BrainQ offers a non-invasive technology to treat a swath of neurological issues. Their device, LearQ, uses proprietary algorithms to create tailored electromagnetic fields, which target patients’ impaired neural networks; thus, recovering their connectivity and enhancing natural rehabilitation. The company’s first area of focus – the treatment of upper limb disability following stroke – affects 900,000 people in the U.S. and E.U. every year. At this time, there are limited treatments are available for the recovery of patients with stroke. BrainQ is hoping to address this need.
- Intendu aims to improve cognitive rehabilitation of people with brain dysfunction. Their platform — already in use in U.S. hospitals – is centered on adaptive, body-controlled video games that mimic real-life interactive scenarios. The games are personalized in real-time to fit the player’s capabilities and rehabilitation goals. Intendu’s solution is particularly useful for patients with cognitive impairments due to traumatic brain injury, stroke, age-related cognitive decline, mental illness, or neurological disease.
Interested to see and learn more about this space? Israel’s best and brightest will be on display for the international medical technology community this May 23-25 in Tel Aviv at the 16th MIXiii-BIOMED 2017 Conference and Exhibition. Aging is the central theme of this year’s conference, and certainly braintech will be a big part of the ongoing conversation at BioMed, since neurological diseases do affect a significant portion of the elderly population.
What’s it like for an investor to engage with startup investing – including diligence material, conversations with peers, and Q&A with company execs – throughout her day-to-day?
With her smartphone,
- she receives a push notification when a new pre-vetted investment opportunity is announced.
- she invites personal contacts to join her private ‘deal room’ and discuss diligence material.
- she enters a live ‘Ask Me Anything’ session with a funding company’s CEO for firsthand details about growth projections, competitive landscape, team background, and more.
- she has the opportunity to connect with her global peers and industry experts to further discuss investment opportunities.
- she makes investment decisions and acts on them at her pace.
That’s just a glimpse into the experience and tools investors access with the OurCrowd App. Ready to give it a try? We’re hosting our next live “Ask Me Anything” event on the app this Thursday, January 12th, featuring OurCrowd CEO Jon Medved answering questions about the new OC50 Portfolio Index Fund.
Hello from CES 2017! OurCrowd is on the ground in Las Vegas at the world’s most innovative, inspiring and fun global consumer electronics and tech tradeshow.
This year’s show has been amazing, especially since we’ve been hanging with friends and portfolio companies with what seems like round-the-clock major announcements since last Thursday.
Take a look at our portfolio’s big news to come out of CES in the last few days:
VocalZoom pairs with Honda
- VocalZoom joins Honda at CES to demonstrate optical sensor that delivers safer automotive voice control
- Honda partners with VocalZoom to advance speech-recognition technology [SAE International]
- Watch here as Honda announces the partnership:
Consumer Physics integrated into smartphone
- Changhong’s H2 smartphone lets you scan objects for molecular authenticity [Venture Beat]
- This phone has a built-in tricorder. Really. [Mashable]
- Now meet the phone with SCiO built in, up close:
Celeno partners with Airgain and NGCodec
- Celeno, a leader in next-gen WiFi semiconductors, announces partnerships with Airgain on Smart Antennas [CED Magazine]
- …as well as with NGCodec for Wireless Virtual Reality [App Developer Magazine]
Argus Cyber Security working with Qualcomm and Elektrobit
- Argus Cyber Security, the world’s largest independent automotive cybersecurity company, announces partnerships with Qualcomm
- …and they paired up with Elektrobit to collaborate to advance the adoption of cybersecurity in autonomous cars
Stringify crowned a top innovator and cool product
- Stringify, the IoT home automation software platform, is named one of the 2017 CES Innovation Awardees
- …and listed as one of the Cool Products from CES Unveiled
Pixie gets rave reviews
- Pixie’s ‘location of things’ platform wows the reviews, named one of the “9 must see products at CES” [Entrepreneur]
- Pixie turns finding your stuff into a game, while the competition is “usually pretty dull” [Engadget]
For photos coming in live from the hall, check out our Facebook album:
Alas, all good things come to end… right?
The 2017 OurCrowd Global Investor Summit is 39 days away.
For more amazing tech, startup demos and investing news, visit the capital of Startup Nation this February. Interact with the entrepreneurs, industry leaders and investors behind the technology changing the world.
If you haven’t grabbed a seat yet, apply now. Preview here:
Israel’s biomed industry is in full bloom; Don’t believe us? Let the numbers speak for themselves! Here are some stats that paint a quick picture of the industry growth:
- 1,380: the number of active biomed companies in the Startup Nation, an all-time high.
- 280: the number of R&D centers operating in Israel for foreign companies, including healthcare, for example: Johnson & Johnson, Philips, General Electric, Merck Serono, Abbott.
- $801 million: the amount raised from venture capital firms in 2014, which was 24% of all VC investments, showing recovery since the 2008/9 financial crisis.
- $2.9B: total sum of Israeli life science company acquisitions in 2013-14.
Earlier this week, IATI released the 2015 Israel Life Sciences Industry Report that, in addition to the above-mentioned data, outlines the state of the biomed industry in the Startup Nation, including the investment landscape. OurCrowd is rated the “second most active life sciences investor in 2014,” right after VC firm OrbiMedIsrael Partners. With medtech encompassing 21% of OurCrowd’s investment portfolio, it would seem we are in line with the greater VC ecosystem in Israel.
This indeed calls for a celebration. Luckily, it just so happens to be BioMed week in Israel: IATI’s major life sciences conference brings together thousands of healthcare industry professionals from around the world to scope out Israeli and global biomed technologies. The event is taking place May 12th-14th, 2015, in the Tel Aviv Convention Center, and OurCrowd and doing its part in sharing, and leading, in the festivities!
OurCrowd at the IATI BioMed 2015 Conference
OurCrowd is participating as an exhibitor, showcasing our medtech portfolio and meeting with the global medtech community. Come by and visit us at Jerusalem BioBooth #140!
Today, OurCrowd’s Venture Partner and medtech investment advisor, Dr. Morris Laster, and Head of OurCrowd Medical Advisory Board, Dr. S. Morry Blumenfeld, held a one-on-one Q&A session at the Jerusalem BioBooth in the Exhibition Hall.
View Morry’s one-on-one Q&A session below or here:
Missed their session? Couldn’t make it to the conference?
There’s another chance to engage with OurCrowd’s Dr. Laster next week:
Join us for Ask Morris Anything, OurCrowd’s first AMA event. Dr. Laster will discuss the medical cannabis industry, including the industry, the current roadblocks, and the technology behind a leading medical cannabis delivery solution. Learn more and submit your questions.
Want to hear more about investment opportunities in the medtech industry in general and the Startup Nation in particular? Sign up on OurCrowd’s website here.
Director of Marketing
|Liz brings a decade of branding, marketing and content experience to her goal of sharing OurCrowd’s vision with the world.|
Something old, something new, something borrowed… is a big opportunity in the online lending market.
In December 2014, investors with a keen eye on the world of fintech witnessed history in the making. First, Lending Club, an online peer-to-peer lending marketplace for unsecured consumer debt, began trading on the NYSE and within the month, had a valuation of over $9 billion. OnDeck, a web-based small business lender, followed suit with their IPO on December 17th, with a valuation at $1.5 billion.
Shortly after, KPMG released its recent ranking of the best, most disruptive financial service tech companies. Not surprisingly, Lending Club and OnDeck ranked high in their 50 Best Fintech Innovators Report, at #6 and #7, respectively.
That’s just the beginning of the story; there are a lot of reasons why the relatively young online lending industry heated up at the end of 2014 and will power investment opportunities through 2015. Before we go any further, let’s take a step back and understand what today’s online lending market fully entails.
The Good, the Big, and the Ugly: A Look at the Lending Industry
According to estimates, lending institutions generate $870+ billion each year in fees and interest from over $3.2 trillion in lending. Considered another way, the lending industry is larger than the automobile and airline industries combined.
But it hasn’t all been rosy from the consumer point of view: During the Global Financial Crisis of 2008-2009, when consumers and small businesses needed access to credit more than ever, many banks stopped offering loans and lines of credit. The combination of this liquidity crunch, new bank regulations, and increased dissatisfaction with the quality and cost of banking services, resulted in significant friction in the traditional lending industry and set the stage for the emergence of one of the hottest sectors of innovation in the world today: alternative finance and online lending.
The online lending market covers a lot of area; to divide by target, there are business and consumer loans. Drilling down further, loans are categorized as unsecured and secured. (For the sake of this article, we will focus on consumer lending.)
For a brief overview of the industry’s current players, check out Orchard’s recent infographic charting the greater online lending ecosystem:
Consumer Lending: Unsecured loans
An unsecured loan (also known as signature loan or personal loan) is a loan that “is issued and supported only by the borrower’s creditworthiness, rather than by a type of collateral.” (Investopedia)
By definition, unsecured loans are bigger risks to the lender. With no guarantee of collateral – like property, luxury asset, or other tangible good – lenders can’t be completely sure they will see returns. Interest rates are higher, and the interest collected on unsecured loans is not tax deductible.
Two well-known examples of unsecured lending platforms that take credit history into account are Lending Club, as mentioned above, and Prosper, (#15 on KPMG’s list) which is another leader in peer-to-peer lending. Pave and Upstart are also examples, but these companies do not facilitate loans based on credit history; instead, they forecast borrowers’ likeliness to be able to repay based on specific factors like education and experience.
Consumer Lending: Secured loans
The flip side of the unsecured loan is the secured loan: this is a transaction where the borrower pledges collateral to ensure payback of the loan. The collateral is usually a high-worth item like a car, piece of jewelry, or even property. If the borrower cannot pay back the debt, the lender can sell the item to regain the money lost.
To date, companies who deal in the secured loan model – or asset-backed lending – have been traditional, offline lenders. Corporate entities have the option of these kinds of services through national investment banks and regional banks.
Now consumers have an up-and-coming online option: Borro. What Lending Club and OnDeck have done for the unsecured consumer lending and small business loan verticals, Borro is doing for the multi-billion dollar personal/luxury asset-backed segment. Borro fills an important void in the lending market: it enables asset-rich individuals to monetize their luxury items for short term liquidity without having to sell them. The company also made KPMG’s list at #8, closely following the two recent IPO success stories.
‘Interest’ in Online Lending: The Opportunity for Investors
As investors in startups, we’re always seeking the next breakout opportunities – that are, of course, also market-proven. Lending Club’s IPO paved the way for the next class of successful online finance companies. We hope that Borro will be leading this class, and invite you to join us.
Director of Marketing
|Liz brings a decade of branding, marketing and content experience to her goal of sharing OurCrowd’s vision with the world.|